Core Insights - The stock price of Aojiahua increased by 2.01% on November 4, reaching 7.12 CNY per share, with a total market capitalization of 4.439 billion CNY [1] - Aojiahua's main business involves the design, research and development, production, and sales of various massage devices, with a revenue composition of 72.58% from massage health products [1] Financial Performance - For the period from January to September 2025, Aojiahua achieved a revenue of 3.724 billion CNY, representing a year-on-year growth of 8.43%, and a net profit attributable to shareholders of 55.2741 million CNY, also showing an increase of 8.37% [2] - Cumulative cash dividends since Aojiahua's A-share listing amount to 1.275 billion CNY, with 436 million CNY distributed over the past three years [3] Shareholder and Market Activity - As of September 30, 2025, the number of Aojiahua's shareholders decreased by 9.49% to 34,300, while the average circulating shares per person increased by 10.48% to 12,838 shares [2] - The stock has seen a price increase of 9.20% year-to-date, with a 2.59% rise over the last five trading days [1]

Group 1 - The other home appliance sector experienced a decline of 0.23% on the trading day, with Rongtai Health leading the drop [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] - Key stocks in the other home appliance sector showed varied performance, with Aojiahua at 6.98 (+0.29%), Rongtai Health at 29.88 (-0.76%), and Rongjie Health at 4.46 (+0.22%) [1] Group 2 - The net outflow of main funds in the other home appliance sector was 4.78 million yuan, while retail investors saw a net inflow of 7.07 million yuan [1] - Detailed fund flow for key stocks indicated significant outflows for Rongtai Health (-3.00%), Aojiahua (-3.37%), and Rongjie Health (-12.46%) [1] - Despite the overall outflow, Aojiahua and Rongjie Health saw some positive retail investor interest, with inflows of 2.44% and 11.75% respectively [1]

Core Insights - The other home appliance sector increased by 1.63% on October 31, with Rongjie Health leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Sector Performance - Rongjie Health (300247) closed at 4.45, up 2.53% with a trading volume of 220,000 shares and a transaction value of 97.4252 million yuan [1] - Qijiahua (002614) closed at 6.96, up 1.75% with a trading volume of 98,400 shares [1] - Rongtai Health (603579) closed at 30.11, up 1.04% with a trading volume of 71,100 shares and a transaction value of 211 million yuan [1] Capital Flow - The other home appliance sector experienced a net outflow of 19.3798 million yuan from institutional funds and 4.1645 million yuan from speculative funds, while retail investors saw a net inflow of 23.5443 million yuan [1] - Specific capital flows for individual stocks include: - Rongjie Health: net outflow of 3.2460 million yuan from institutional funds, net inflow of 1.6836 million yuan from retail investors [1] - Qijiahua: net outflow of 3.8153 million yuan from institutional funds, net inflow of 3.0156 million yuan from retail investors [1] - Rongtai Health: net outflow of 17.1270 million yuan from institutional funds, net inflow of 18.8451 million yuan from retail investors [1]

Group 1 - The company has established several wholly-owned subsidiaries, including Zhangzhou OJIAHUA Intelligent Health Equipment Co., Ltd., which was founded in January 2018 with a registered capital of 567.52 million RMB [2][3] - The company has also established subsidiaries such as Madebokan (Xiamen) Trading Co., Ltd. and Zhangzhou Mengfali Medical Technology Co., Ltd., focusing on various sectors including medical devices and smart home appliances [4][5] - The company is planning to provide guarantees for its subsidiaries' operational needs in 2026, which is expected to enhance financing efficiency and reduce operational costs [12][13][15] Group 2 - The total amount of guarantees provided by the company and its subsidiaries as of September 30, 2025, is 354 million RMB, accounting for 7.99% of the latest audited net assets [16] - The company has no overdue guarantees or any litigation related to guarantees, indicating a stable financial position [16] - The company is set to hold its second extraordinary general meeting of 2025 on November 17, 2025, to discuss various proposals [18][19][22]

Core Points - The company has approved the use of temporarily idle raised funds and its own funds to purchase financial products with high safety and liquidity, not exceeding 10,000 million yuan of temporarily idle raised funds and 200,000 million yuan of its own funds [9][69] - The company aims to maximize shareholder interests by improving the efficiency of temporarily idle funds while ensuring that the normal operation of fundraising projects is not affected [41][80] - The company plans to apply for a comprehensive credit limit of 555,000 million yuan from banks for the year 2026, which requires approval from the second extraordinary general meeting of shareholders in 2025 [10][56] - The company intends to conduct foreign exchange hedging activities for an amount not exceeding 36,000 million USD in 2026 to mitigate the risks associated with exchange rate fluctuations [59][63] Financial Data - As of September 30, 2025, the company has raised a total of 1,200 million yuan through convertible bonds, with a net amount of 1,186,226,415.09 yuan after deducting issuance costs [37][69] - The company reported a temporary idle balance of 9,950 million yuan from the raised funds, which has been used for fixed deposits [40][71] Shareholder Information - The company’s board of directors has confirmed that the financial report is true, accurate, and complete, with no false records or misleading statements [2][6] - The company has a total of 9 directors present at the board meeting, all of whom voted in favor of the resolutions [8][10] Risk Management - The company has established strict risk control measures for the investment in financial products, ensuring that only low-risk products are purchased and that funds are managed by designated personnel [48][79] - The company’s audit department will supervise the financial product business, conducting pre-audit, ongoing supervision, and post-audit [50][79]

Core Viewpoint - OJIHUA (002614) announced that the company and its subsidiaries have no guarantees provided to entities outside the consolidated financial statements, and there are no overdue guarantees, litigation-related guarantees, or losses incurred due to guarantee-related judgments [1] Summary by Categories - **Company Guarantees** - The company confirmed that there are no guarantees provided to external entities [1] - There are no overdue guarantees reported [1] - **Litigation and Legal Matters** - The company stated that there are no guarantees involved in any litigation [1] - There are no losses incurred from guarantees due to adverse judgments [1]

奥佳华智能健康科技集团股份有限公司 董事、高级管理人员薪酬管理制度 第一章 总则 第一条 为进一步完善奥佳华智能健康科技集团股份有限公司（以下简称"公 司"）董事、高级管理人员的薪酬管理，建立科学有效的激励与约束机制，有效 调动公司董事、高级管理人员的工作积极性和创造性。公司根据《中华人民共和 国公司法》（以下简称"《公司法》"）《上市公司治理准则》《深圳证券交易 所股票上市规则》等法律法规、规范性文件、证券交易所业务规则及《公司章程》 的有关规定，结合公司实际情况，制定本制度。 第二条 本制度适用于下列人员： （一）董事会成员：包括独立董事、非独立董事、职工代表董事； （二）高级管理人员：指公司总经理、副总经理、董事会秘书、财务负责人 及其他《公司章程》中列入高级管理人员范围的人员。 第四条 公司董事、高级管理人员薪酬方案由董事会薪酬与考核委员会制定， 明确薪酬确定依据和具体构成。董事薪酬方案由股东会决定，并予以披露。在董 事会或者薪酬与考核委员会对董事个人进行评价或者讨论其报酬时，该董事应当 回避。 高级管理人员薪酬方案由董事会批准，向股东会说明，并予以充分披露。 公司业绩如果发生亏损，公司应当在董事、高 ...

Group 1 - The company OJH (SZ 002614) announced its sixth board meeting held on October 28, 2025, to discuss the proposal for a comprehensive credit limit application for 2026 [1] - For the first half of 2025, OJH's revenue composition was as follows: massage home appliances accounted for 42.88%, small massage appliances for 29.7%, health environment products for 14.84%, other products for 9.53%, and other business activities for 3.05% [1] - As of the report date, OJH's market capitalization was 4.3 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after ten years of stagnation, with technology leading the market's transformation into a "slow bull" new pattern [1]

Core Viewpoint - Aojiahua (002614.SZ) reported a revenue increase of 8.43% year-on-year for the first three quarters of 2025, reaching 3.724 billion yuan, along with a net profit increase of 8.37% to 55.2741 million yuan [1] Financial Performance - Revenue for the first three quarters of 2025 was 3.724 billion yuan, reflecting an 8.43% increase compared to the previous year [1] - Net profit attributable to shareholders was 55.2741 million yuan, which is an 8.37% increase year-on-year [1] - The net profit after deducting non-recurring gains and losses was 41.8844 million yuan, showing a significant increase of 497.97% year-on-year [1] - Basic earnings per share were reported at 0.09 yuan [1]

奥佳华智能健康科技集团股份有限公司 关于 2026 年度外汇套期保值计划的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 奥佳华智能健康科技集团股份有限公司（以下简称"公司"）于 2025 年 10 月 28 日召开的第六届董事会第十二次会议审议通过了《关于 2026 年度外汇套期 保值计划的议案》，同意公司 2026 年度拟开展不超过 36,000.00 万美元的外汇套 期保值业务，该额度自 2026 年 1 月 1 日至 2026 年 12 月 31 日内有效，资金在上 述额度和期限范围内可循环滚动使用。本事项需提交公司 2025 年第二次临时股 东会审议。现将有关情况公告如下： 一、外汇套期保值业务情况概述 | 证券代码：002614 | 股票简称：奥佳华 | 公告编号：2025-47 号 | | --- | --- | --- | | 债券代码：128097 | 债券简称：奥佳转债 | | 公司于 2025 年 10 月 23 日召开的第六届董事会审计委员会 2025 年第四次会 议及2025年10月 28日召开的第六届董事会第十二次会议审议通过 ...